GlaxoSmithKline

GlaxoSmithKline is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

The company aims to bring differentiated, high-quality and needed healthcare products to as many people as possible, with its 3 global businesses, scientific and technical know-how, and talented people.

GSK's Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in respiratory and HIV. Our R&D approach focuses on science related to the immune system, the use of genetics, and advanced technologies.

The Vaccines business has a broad portfolio and innovative pipeline of vaccines to help protect people throughout life. It delivers over two million vaccine doses per day to people living in over 160 countries.

The Consumer Healthcare business develops and markets an innovative portfolio of consumer preferred and expert-recommended brands in the Pain relief, Respiratory, Digestive health, Oral Health, Nutrition, and Skin health categories.

GlaxoSmithKline, established in 1929 and headquartered in Europe., specializes in Late Stage Venture, Early Stage Venture investments across Information Services, Biotechnology, Developer Platform, Publishing, Venture Capital, Marketing, Financial Services, Finance, Banking, Health Care. The organization boasts a portfolio of 26 investments, with an average round size of $73.9M and 14 successful exits. Their recent investments include Chroma Therapeutics, Gilde IT Fund, Nomura Holdings, Wellcome Trust, Abingworth. The highest investment round they participated in was $83.2B. Among their most notable exits are Chroma Therapeutics and Gilde IT Fund. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.